Literature DB >> 23204818

The nanomedicine revolution: part 3: regulatory and safety challenges.

C Lee Ventola.   

Abstract

Before the FDA can set up safety guidelines for nanomedicines, it needs to establish valid testing criteria. The goal is to strike a balance between underregulation (which can lead to questionable approvals) and overregulation (which can inhibit innovation).

Year:  2012        PMID： 23204818      PMCID： PMC3498993     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  9 in total

Review 1.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Authors:  Paul Galvin; Damien Thompson; Katie B Ryan; Anna McCarthy; Anne C Moore; Conor S Burke; Maya Dyson; Brian D Maccraith; Yurii K Gun'ko; Michelle T Byrne; Yuri Volkov; Chris Keely; Enda Keehan; Michael Howe; Conor Duffy; Ronan MacLoughlin
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

Review 2.  Nanomedicine.

Authors:  Betty Y S Kim; James T Rutka; Warren C W Chan
Journal:  N Engl J Med       Date:  2010-12-16       Impact factor: 91.245

3.  Legal aspects of the risks raised by nanotechnologies in the field of medicine.

Authors:  Isabelle Poirot-Mazères
Journal:  J Int Bioethique       Date:  2011 Mar-Jun

Review 4.  Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.

Authors:  Dhruba J Bharali; Shaker A Mousa
Journal:  Pharmacol Ther       Date:  2010-08-10       Impact factor: 12.310

5.  Regulating nanomedicine - can the FDA handle it?

Authors:  Raj Bawa
Journal:  Curr Drug Deliv       Date:  2011-05       Impact factor: 2.565

Review 6.  From nanotechnology to nanomedicine: applications to cancer research.

Authors:  R Seigneuric; L Markey; D S A Nuyten; C Dubernet; C T A Evelo; E Finot; C Garrido
Journal:  Curr Mol Med       Date:  2010-10       Impact factor: 2.222

Review 7.  Development of multifunctional nanoparticles for targeted drug delivery and noninvasive imaging of therapeutic effect.

Authors:  Hari Krishna Sajja; Michael P East; Hui Mao; Y Andrew Wang; Shuming Nie; Lily Yang
Journal:  Curr Drug Discov Technol       Date:  2009-03

Review 8.  Emerging synergy between nanotechnology and implantable biosensors: a review.

Authors:  Santhisagar Vaddiraju; Ioannis Tomazos; Diane J Burgess; Faquir C Jain; Fotios Papadimitrakopoulos
Journal:  Biosens Bioelectron       Date:  2009-12-11       Impact factor: 10.618

9.  Nanotechnology in medicine: from inception to market domination.

Authors:  Valentina Morigi; Alessandro Tocchio; Carlo Bellavite Pellegrini; Jason H Sakamoto; Marco Arnone; Ennio Tasciotti
Journal:  J Drug Deliv       Date:  2012-03-07
  9 in total
  8 in total

1.  Progress in Nanomedicine: Approved and Investigational Nanodrugs.

Authors:  C Lee Ventola
Journal:  P T       Date:  2017-12

Review 2.  Careers in nanomedicine and drug delivery.

Authors:  Elizabeth Nance
Journal:  Adv Drug Deliv Rev       Date:  2019-06-28       Impact factor: 15.470

Review 3.  Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives.

Authors:  Natasha Manners; Vishnu Priya; Abhishesh Kumar Mehata; Manoj Rawat; Syam Mohan; Hafiz A Makeen; Mohammed Albratty; Ali Albarrati; Abdulkarim M Meraya; Madaswamy S Muthu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-01

Review 4.  Multifunctional nanoparticles for brain tumor imaging and therapy.

Authors:  Yu Cheng; Ramin A Morshed; Brenda Auffinger; Alex L Tobias; Maciej S Lesniak
Journal:  Adv Drug Deliv Rev       Date:  2013-09-20       Impact factor: 15.470

5.  Remotely Triggered Nano-Theranostics For Cancer Applications.

Authors:  Alexandra Sneider; Derek VanDyke; Shailee Paliwal; Prakash Rai
Journal:  Nanotheranostics       Date:  2017

Review 6.  The consolidation of nanomedicine.

Authors:  Raphael Zingg; Marius Fischer
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-06-26

7.  The protein corona protects against size- and dose-dependent toxicity of amorphous silica nanoparticles.

Authors:  Dominic Docter; Christoph Bantz; Dana Westmeier; Hajo J Galla; Qiangbin Wang; James C Kirkpatrick; Peter Nielsen; Michael Maskos; Roland H Stauber
Journal:  Beilstein J Nanotechnol       Date:  2014-08-27       Impact factor: 3.649

Review 8.  Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19.

Authors:  Farzan Vahedifard; Krishnan Chakravarthy
Journal:  Emergent Mater       Date:  2021-02-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.